Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 716

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer 1 1The authors thank Professor T. K. Korhonen (Division of General Microbiology, University of Helsinki, Finland), who kindly donated Escherichia coli IH11165; Professor J.-F. Colombel (Laboratoire de Recherche sur les Maladies Inflammatoire de l’Intestine, Centre Hospitalier Universitaire, Lille, France) and Professor A. Darfeuille-Michaud (Faculte de Pharmacie, Clermont-Ferrand, France), who kindly donated the Crohn’s disease ileal isolates LF10 and LF82; and Dr. Keith Leiper (Gastroenterology Unit, Royal Liverpool & Broadgreen University Hospitals Trust, Liverpool, UK) for his cooperation in obtaining colorectal tissue specimens.As a consequence of the work described herein, a patent application has been filed by the University of Liverpool regarding the use of soluble plantain fiber in Crohn’s disease.

Open access
Martin, Helen M., Campbell, Barry J., Hart, C.Anthony, Mpofu, Chiedzo, Nayar, Manu, Singh, Ravinder, Englyst, Hans, Williams, Helen F., Rhodes, Jonathan M.·2004·Gastroenterology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2004.03.054

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 51

  1. Darfeuille-Michaud, 1998, Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn’s disease, Gastroenterology, 115, 1405, 10.1016/S0016-5085(98)70019-8 · DOI · Paper page
  2. Swidsinski, 2002, Mucosal flora in inflammatory bowel disease, Gastroenterology, 122, 44, 10.1053/gast.2002.30294 · DOI · Paper page
  3. Boudeau, 1999, Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn’s disease, Infect Immun, 67, 4499, 10.1128/IAI.67.9.4499-4509.1999 · DOI · Paper page
  4. Glasser, 2001, Adherent invasive Escherichia coli strains from patients with Crohn’s disease survive and replicate within macrophages without inducing host cell death, Infect Immun, 69, 5529, 10.1128/IAI.69.9.5529-5537.2001 · DOI · Paper page
  5. Liu, 1995, Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn’s disease, Gastroenterology, 108, 1396, 10.1016/0016-5085(95)90687-8 · DOI · Paper page
  6. Hugot, 2001, Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease, Nature, 411, 599, 10.1038/35079107 · DOI · Paper page
  7. Ogura, 2001, A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease, Nature, 411, 603, 10.1038/35079114 · DOI · Paper page
  8. Lala, 2003, Crohn’s disease and the NOD2 gene, Gastroenterology, 125, 47, 10.1016/S0016-5085(03)00661-9 · DOI · Paper page
  9. Gutierrez, 2002, Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation, J Biol Chem, 277, 41701, 10.1074/jbc.M206473200 · DOI · Paper page
  10. O’Riordan, 2002, Innate recognition of bacteria by a macrophage cytosolic surveillance pathway, Proc Natl Acad Sci U S A, 99, 13861, 10.1073/pnas.202476699 · DOI · Paper page
  11. Inohara, 2003, Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn’s disease, J Biol Chem, 278, 5509, 10.1074/jbc.C200673200 · DOI · Paper page
  12. Chamaillard, 2003, Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases, Proc Natl Acad Sci U S A, 100, 3455, 10.1073/pnas.0530276100 · DOI · Paper page
  13. Girardin, 2003, Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection, J Biol Chem, 278, 8869, 10.1074/jbc.C200651200 · DOI · Paper page
  14. Rhodes, 2002, Inflammation and colorectal cancer, Trends Mol Med, 8, 10, 10.1016/S1471-4914(01)02194-3 · DOI · Paper page
  15. Swidsinski, 1998, Association between intraepithelial Escherichia coli and colorectal cancer, Gastroenterology, 115, 281, 10.1016/S0016-5085(98)70194-5 · DOI · Paper page
  16. Klemm, 2000, Bacterial adhesins, Int J Med Microbiol, 290, 27, 10.1016/S1438-4221(00)80102-2 · DOI · Paper page
  17. Soto, 1999, Bacterial adhesins, J Bacteriol, 181, 1059, 10.1128/JB.181.4.1059-1071.1999 · DOI · Paper page
  18. Henry, 2001, Molecular diversity in the biosynthesis of GI tract glycoconjugates. A blood-group-related chart of microorganism receptors, Transfus Clin Biol, 8, 226, 10.1016/S1246-7820(01)00112-4 · DOI
  19. Campbell, 1995, Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin, J Clin Invest, 95, 571, 10.1172/JCI117700 · DOI
  20. Campbell, 2001, Altered glycosylation in inflammatory bowel disease, Glycoconj J, 18, 851, 10.1023/A:1022240107040 · DOI
  21. Hakomori, 2002, Glycosylation defining cancer malignancy, Proc Natl Acad Sci U S A, 99, 10231, 10.1073/pnas.172380699 · DOI · Paper page
  22. Kim, 1996, Mucin glycoproteins in neoplasia, Glycoconj J, 13, 693, 10.1007/BF00702333 · DOI · Paper page
  23. Ryder, 1994, Peanut lectin stimulates proliferation in colonic explants from patients with inflammatory bowel disease and colon cancer, Gastroenterology, 106, 117, 10.1016/S0016-5085(94)94775-9 · DOI
  24. Ryder, 1998, Peanut ingestion increases rectal proliferation in individuals with mucosal expression of peanut lectin receptor, Gastroenterology, 114, 44, 10.1016/S0016-5085(98)70631-6 · doi:10.1016/s0016-5085(98)70631-6
  25. Rhodes, 1996, Unifying hypothesis for inflammatory bowel disease and associated colon cancer, Lancet, 347, 40, 10.1016/S0140-6736(96)91563-9 · DOI
  26. Daigle, 1994, Expression and detection of pap-, sfa-, and afa-encoded fimbrial adhesin systems among uropathogenic Escherichia coli, Can J Microbiol, 40, 286, 10.1139/m94-046 · doi:10.1139/m94-046
  27. Tsen, 1998, Development and use of a multiplex PCR system for the rapid screening of heat labile toxin I, heat stable toxin II and shiga-like toxin I and II genes of Escherichia coli in water, J Appl Microbiol, 84, 585, 10.1046/j.1365-2672.1998.00385.x · doi:10.1046/j.1365-2672.1998.00385.x
  28. Pass, 2000, Multiplex PCRs for identification of Escherichia coli virulence genes, J Clin Microbiol, 38, 2001, 10.1128/JCM.38.5.2001-2004.2000 · DOI · Paper page
  29. Barrett, 1994, Laboratory investigation of a multistate food-borne outbreak of Escherichia coli O157, J Clin Microbiol, 32, 3013, 10.1128/JCM.32.12.3013-3017.1994 · doi:10.1128/jcm.32.12.3013-3017.1994
  30. Le Bouguenec, 2001, Characterization of AfaE adhesins produced by extraintestinal and intestinal human Escherichia coli isolates, J Clin Microbiol, 39, 1738, 10.1128/JCM.39.5.1738-1745.2001 · DOI
  31. Thomas, 2001, Cytotoxic necrotizing factor from Escherichia coli induces RhoA-dependent expression of the cyclooxygenase-2 gene, Infect Immun, 69, 6839, 10.1128/IAI.69.11.6839-6845.2001 · DOI
  32. Schultsz, 1997, Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls, J Clin Pathol, 50, 573, 10.1136/jcp.50.7.573 · DOI
  33. Burke, 1988, Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea, Br Med J, 297, 102, 10.1136/bmj.297.6641.102 · DOI
  34. Giaffer, 1992, Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease, Gut, 33, 646, 10.1136/gut.33.5.646 · DOI · Paper page
  35. Fujita, 2002, Quantitative analysis of bacterial DNA from Mycobacteria spp., Bacteroides vulgatus, and Escherichia coli in tissue samples from patients with inflammatory bowel diseases, J Gastroenterol, 37, 509, 10.1007/s005350200079 · DOI
  36. Yamamato, 1991, Characteristics of adherence of enteroaggregative Escherichia coli to human and animal mucosa, Infect Immun, 59, 3722, 10.1128/IAI.59.10.3722-3739.1991 · DOI
  37. Hisamatsu, 2003, CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells, Gastroenterology, 124, 993, 10.1053/gast.2003.50153 · DOI · Paper page
  38. Isaacs, 1985, Chronic granulomatous disease mimicking Crohn’s disease, J Pediatr Gastroenterol Nutr, 4, 498, 10.1097/00005176-198506000-00030 · doi:10.1097/00005176-198506000-00030
  39. Couper, 1991, Neutrophil dysfunction in glycogen storage disease Ib, Gastroenterology, 100, 549, 10.1016/0016-5085(91)90229-E · doi:10.1016/0016-5085(91)90229-e
  40. King, 1988, Phagocytosis and killing of Listeria monocytogenes by alveolar macrophages, J Infect Dis, 158, 1309, 10.1093/infdis/158.6.1309 · DOI
  41. Hand, 1987, Entry of roxithromycin (RU965), imipenem, cefotaxime, trimethoprim, and metronidazole into human polymorphonuclear leukocytes, Antimicrob Agents Chemother, 31, 1553, 10.1128/AAC.31.10.1553 · doi:10.1128/aac.31.10.1553
  42. Dawsey, 2002, Gastric cancer and H pylori, Gut, 51, 457, 10.1136/gut.51.3.457 · doi:10.1136/gut.51.3.457
  43. Cebra, 1999, Influences of microbiota on intestinal immune system development, Am J Clin Nutr, 69, 1046S, 10.1093/ajcn/69.5.1046s · DOI · Paper page
  44. Wehkamp, 2002, Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease, Eur J Gastroenterol Hepatol, 14, 745, 10.1097/00042737-200207000-00006 · DOI · Paper page
  45. Rath, 1999, Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli, Infect Immun, 67, 2969, 10.1128/IAI.67.6.2969-2974.1999 · DOI · Paper page
  46. Leiper, 2001, Interaction between bacterial peptides, neutrophils and goblet cells, Clin Sci, 101, 395, 10.1042/CS20010078 · doi:10.1042/cs20010078
  47. Anton, 1998, Mucosal subepithelial binding sites for the bacterial chemotactic peptide, formyl-methionyl-leucyl-phenylalanine (FMLP), Gut, 42, 374, 10.1136/gut.42.3.374 · doi:10.1136/gut.42.3.374
  48. Rhen, 1986, Organization of genes expressing the blood-group-M-specific haemagglutinin of Escherichia coli, Gene, 49, 351, 10.1016/0378-1119(86)90371-9 · DOI
  49. Gerken, 1989, Effects of glycosylation on the conformation and dynamics of O-linked glycoproteins, Biochemistry, 28, 5536, 10.1021/bi00439a030 · DOI
  50. Karlen, 1998, Sialyl-Tn antigen as a marker of colon cancer risk in ulcerative colitis, Gastroenterology, 115, 1395, 10.1016/S0016-5085(98)70018-6 · doi:10.1016/s0016-5085(98)70018-6
  51. Chai, 1992, Characterisation by mass spectrometry and 1H-NMR of novel hexasaccharides among the acidic O-linked carbohydrate chains of bovine submaxillary mucin, Eur J Biochem, 207, 973, 10.1111/j.1432-1033.1992.tb17132.x · doi:10.1111/j.1432-1033.1992.tb17132.x

Cited by

See all 716

Metadata

Authors
Martin, H. M., Campbell, B. J., Hart, C. A., Mpofu, C., Nayar, M., Singh, R., Englyst, H., Williams, H. F., & Rhodes, J. M.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2004-07
Volume
127
Issue
1
Pages
80-93
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2169909966
Cited by
716
References
1
FWCI
11.45
Type
journal article
Language
en
Open access
bronze
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer 1 1The authors thank Professor T. K. Korhonen (Division of General Microbiology, University of Helsinki, Finland), who kindly donated Escherichia coli IH11165; Professor J.-F. Colombel (Laboratoire de Recherche sur les Maladies Inflammatoire de l’Intestine, Centre Hospitalier Universitaire, Lille, France) and Professor A. Darfeuille-Michaud (Faculte de Pharmacie, Clermont-Ferrand, France), who kindly donated the Crohn’s disease ileal isolates LF10 and LF82; and Dr. Keith Leiper (Gastroenterology Unit, Royal Liverpool & Broadgreen University Hospitals Trust, Liverpool, UK) for his cooperation in obtaining colorectal tissue specimens.As a consequence of the work described herein, a patent application has been filed by the University of Liverpool regarding the use of soluble plantain fiber in Crohn’s disease. https://app.cochat.ai/papers/10.1053/j.gastro.2004.03.054
The paper
Martin, H. M., Campbell, B. J., Hart, C. A., Mpofu, C., Nayar, M., Singh, R., Englyst, H., Williams, H. F., & Rhodes, J. M. (2004). Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer 1 1The authors thank Professor T. K. Korhonen (Division of General Microbiology, University of Helsinki, Finland), who kindly donated Escherichia coli IH11165; Professor J.-F. Colombel (Laboratoire de Recherche sur les Maladies Inflammatoire de l’Intestine, Centre Hospitalier Universitaire, Lille, France) and Professor A. Darfeuille-Michaud (Faculte de Pharmacie, Clermont-Ferrand, France), who kindly donated the Crohn’s disease ileal isolates LF10 and LF82; and Dr. Keith Leiper (Gastroenterology Unit, Royal Liverpool & Broadgreen University Hospitals Trust, Liverpool, UK) for his cooperation in obtaining colorectal tissue specimens.As a consequence of the work described herein, a patent application has been filed by the University of Liverpool regarding the use of soluble plantain fiber in Crohn’s disease. Gastroenterology. https://doi.org/10.1053/j.gastro.2004.03.054

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.